BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11883526)

  • 1. Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes.
    Collins CM; Medveczky PG
    Adv Cancer Res; 2002; 84():155-74. PubMed ID: 11883526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome.
    Lim C; Sohn H; Lee D; Gwack Y; Choe J
    J Virol; 2002 Oct; 76(20):10320-31. PubMed ID: 12239308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
    Hu J; Garber AC; Renne R
    J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1.
    Shinohara H; Fukushi M; Higuchi M; Oie M; Hoshi O; Ushiki T; Hayashi J; Fujii M
    J Virol; 2002 Dec; 76(24):12917-24. PubMed ID: 12438617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.
    Cotter MA; Subramanian C; Robertson ES
    Virology; 2001 Dec; 291(2):241-59. PubMed ID: 11878894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome.
    Collins CM; Medveczky MM; Lund T; Medveczky PG
    J Gen Virol; 2002 Sep; 83(Pt 9):2269-2278. PubMed ID: 12185282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2.
    Griffiths R; Whitehouse A
    J Virol; 2007 Apr; 81(8):4021-32. PubMed ID: 17267510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORF73 of herpesvirus Saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats.
    Verma SC; Robertson ES
    J Virol; 2003 Dec; 77(23):12494-506. PubMed ID: 14610173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a virus trans-acting regulatory element on the latent DNA replication of Kaposi's sarcoma-associated herpesvirus.
    Lim C; Seo T; Jung J; Choe J
    J Gen Virol; 2004 Apr; 85(Pt 4):843-855. PubMed ID: 15039527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNA.
    Srinivasan V; Komatsu T; Ballestas ME; Kaye KM
    J Virol; 2004 Dec; 78(24):14033-8. PubMed ID: 15564510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.
    Ballestas ME; Kaye KM
    J Virol; 2001 Apr; 75(7):3250-8. PubMed ID: 11238851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.
    Hellert J; Weidner-Glunde M; Krausze J; Lünsdorf H; Ritter C; Schulz TF; Lührs T
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6694-9. PubMed ID: 25947153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Garber AC; Shu MA; Hu J; Renne R
    J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA.
    Messick TE; Tolvinski L; Zartler ER; Moberg A; Frostell Å; Smith GR; Reitz AB; Lieberman PM
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.
    Kwun HJ; da Silva SR; Shah IM; Blake N; Moore PS; Chang Y
    J Virol; 2007 Aug; 81(15):8225-35. PubMed ID: 17522213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
    Sun Z; Jha HC; Robertson ES
    J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
    Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
    De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
    PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.
    Weidner-Glunde M; Mariggiò G; Schulz TF
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.